| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.0M | — |
| R&D Expense | $23.1M | -0.8% |
| SG&A Expense | $19.7M | +44.2% |
| Operating Income | -$109.5M | -196.8% |
| Income Tax | $0 | — |
| Net Income | -$106.8M | -189.5% |
| EPS (Basic) | -$5.38 | -74.1% |
| EPS (Diluted) | -$5.38 | -74.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $98.7M | +385.6% |
| Current Assets | $144.7M | +538.9% |
| Total Assets | $148.5M | +517.7% |
| Current Liabilities | $21.8M | +197.8% |
| Total Liabilities | $28.7M | +287.6% |
| Stockholders' Equity | $119.9M | +619.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.6M | +73.6% |
| Capital Expenditures | $831K | +235.1% |
| Investing Cash Flow | -$30.5M | — |
| Financing Cash Flow | $116.4M | — |
| Free Cash Flow | -$8.4M | +71.0% |